REGENERX BIOPHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCKRegenerx Biopharmaceuticals Inc • May 15th, 2019 • Pharmaceutical preparations • Delaware
THIS CERTIFIES THAT, for value received, _______________, or his permitted registered assigns (the “Holder”), is entitled to subscribe for and purchase at the Exercise Price (defined below) from REGENERX BIOPHARMACEUTICALS, INC., a Delaware corporation (the “Company”) up to 78,125 shares of the common stock of the Company, par value $0.001 per share (the “Common Stock”). This Warrant has been issued pursuant to that certain Securities Purchase Agreement between the Company and the Holder dated of even date herewith (the “Purchase Agreement”).
REGENERX BIOPHARMACEUTICALS, INC. CONVERTIBLE NOTE AND WARRANT PURCHASE AGREEMENT February [__], 2019Convertible Note and Warrant Purchase Agreement • May 15th, 2019 • Regenerx Biopharmaceuticals Inc • Pharmaceutical preparations
THIS CONVERTIBLE NOTE AND WARRANT PURCHASE AGREEMENT (this “Agreement”), dated as of February 26, 2019, is entered into by and between RegeneRx Biopharmaceuticals, Inc., a Delaware corporation (the “Company”), and _________, a resident of ________ (the “Investor”).
